Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Colchicine for Troponin I in Severe RA
NCT04056039Phase 2Completed
- Sponsor
- Hospital Central Dr. Ignacio Morones Prieto
- Start
- Aug 2018
- Primary completion
- Jun 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in rheumatoid arthritis (RA) comparing Atorvastatin with Colchicine (2 arms). Primary endpoint: Changes of high sensitivity troponin I levels at 4 weeks. Started Aug 2018; status: completed.
02
Drugs
atorvastatincolchicine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04056039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056039.